Sonya Reid, MD, MPH
Assistant Professor in the Division of Hematology/Oncology
Conquer Cancer, The ASCO Foundation
Expanding our understanding of the association between race, genetics, and breast cancer survival.
Despite a steady improvement in breast cancer survival rates over the past several decades, Black women are 42 percent more likely to die from breast cancer compared to white women. The factors which contribute to disparities among racial groups is complex and likely has to do with a variety of circumstances, including tumor biology, genetics, access to healthcare, and other social determinants of health. Still today, however, we do not fully understand how genetics influence racial disparities and the survival of women with breast cancer. This is due, in part, to a significant under-representation of Black women in breast cancer research studies. Dr. Sonya Reid’s Conquer Cancer study supported by BCRF will gather breast tumor samples and medical records from Black and non-Hispanic white women, and analyze how different clinical and genetic features affect breast cancer recurrence and survival across different racial groups.
The team collected 106 breast cancer tumor samples from patients born with a mutation in one of the breast cancer predisposition genes, BRCA1, BRCA2, or PALB2. They are currently performing genetic and molecular analyses, while also collecting medical records and recording patient demographics and tumor clinical characteristics.
Tissue samples and medical records will be collected from a total of 600 patients. Dr. Reid and her team will assess if there are any connections between race, inherited breast cancer genes, and clinicopathological features (e.g., age at diagnosis, tumor subtype, stage at diagnosis); and if any of these differences are associated with rates of breast cancer recurrence and survival. They will also explore if mutations in tumors (those that are not inherited, but occur during the course of tumor development), contribute to disparities in breast cancer outcomes across racial groups, including response to different chemotherapies.
Sonya Reid, MD, MPH is an Assistant Professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center (Vanderbilt Ingram Cancer Center). Her research primarily focuses on health disparities in breast cancer, young-onset breast cancer, and hereditary breast cancer. Specifically, she is investigating genomic differences that may be contributing to the racial survival disparity in breast cancer. Dr. Reid is also focused on improving health care delivery to underserved communities and increasing the representation of minority patients in clinical trials. She is also actively involved in breast cancer research in Jamaica and recently completed a Master of Public Health degree from Vanderbilt University with a focus on Global health. Dr. Reid received the Martin Luther King Jr. award in recognition of her work in diversity, inclusion, and equity at Vanderbilt University Medical Center. Clinically, she focuses on caring for breast cancer patients with a special interest in high-risk patients.
The Estée Lauder Companies' Corporate Award
When you give to BCRF, you're funding critical hours in the lab. More time for research means longer, healthier lives for the ones we love.